Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  methoxsalen
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-12 of 12 for your search:
Start Over
Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ECTCL1, NCT00221039
Phase III Comparison of Electron Beam Radiotherapy plus ADR/CTX/VP-16/VCR vs Topical Therapy for Stage I/II/III/IV Mycosis Fungoides and Sezary Syndrome
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-79-C-70, NCI-NMOB-816, NCI-T83-1451N, NCI-N81-900, N81-0900
Phase I/II Study of Roferon-A plus PUVA Therapy in Patients with Cutaneous T-Cell Lymphoma (Summary Last Modified 08/89)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: UCHSC-88036, NCI-V88-0558
Phase II Study of PUVA with Cyclosporine and Thalidomide as Treatment for Chronic Graft-Versus-Host Disease (Summary Last Modified 12/98)
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: any age
Sponsor: Other
Protocol IDs: JHOC-9319, JHUSM-FDR001240, NCI-V96-0896
Phase II Study of the UVAR Photopheresis System in Conjunction with Methoxsalen (Uvadex) for the Treatment of Chronic Graft Versus Host Disease (Summary Last Modified 01/99)
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: RPCI-DS-96-12, THERAKOS-RPCI-DS-96-12, NCI-G97-1239
Phase II Study of a Reduced-Intensity Preparative Regimen With Allogeneic Bone Marrow Transplantation in Patients With Myelodysplastic Syndromes
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: ECOG-E1902, NCT00045305, E1902
Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: umcc 2008.003, NCT00639717
Start Over